Quantcast

Latest Immunohistochemistry Stories

2011-03-03 07:25:13

Lung cancer is considered the 6th most common cause of cancer deaths in the United States.

2011-02-25 13:14:17

An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.

2011-02-12 00:00:46

Today a digitized, or computerized, form of immunohistochemistry (IHC) is revolutionizing the clinical pathology industry, helping pathologists make diagnoses with improved accuracy, efficiency and speed are invaluable to the doctors and their patients who rely on pathology results.

2011-01-20 14:41:00

ROCKVILLE, Md., Jan. 20, 2011 /PRNewswire/ -- OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand.

2010-11-12 10:44:00

BRANFORD, Conn., Nov. 12, 2010 /PRNewswire/ -- HistoRx, Inc. (privately held), a diagnostics company, announced the launch and first commercial sale this week of clinical diagnostic assays based on AQUA® technology. Genoptix, Inc.

2010-08-09 08:00:00

BURLINGAME, Calif., Aug. 9 /PRNewswire/ -- Epitomics, Inc., the rabbit monoclonal antibody company, announces today the launch of EP Clone(TM) Rabbit Monoclonal Antibodies and their detection systems for pathology applications.

2010-06-16 05:00:00

ALISO VIEJO, Calif., June 16 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that Neal S. Goldstein, M.D., has been named the Company's Director of Surgical Pathology.

2010-05-12 16:32:00

NEW HAVEN, Conn., May 12 /PRNewswire/ -- HistoRx , Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers. U.S. Patent No.

2010-02-19 16:00:00

CARLSBAD, Calif. and NEW HAVEN, Conn., Feb. 19 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory service provider, and HistoRx, Inc.

2010-02-10 08:54:45

Previous studies have shown that assessment of immunoglobulin subclasses in plasma cells by immunohistochemistry (IHC) may be useful in the histopathologic evaluation of autoimmune liver diseases.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related